Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
13
Bearish filings
197
Named actors
24
Disclosed $ (bull / bear)
$17.0M + 7 of unknown size / $88.3M + 7 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-15 | Officer (via Morgan Stanley Smith Barney LLC) Anatol Kreitzer | filed notice to sell | $98K | SEC ↗ |
| 2026-10-15 | Chief Executive Officer Kroeger Christopher A. | sold | $595K | SEC ↗ |
| 2026-10-15 | CAO and Interim CFO GILLIS JONATHAN | sold | $82K | SEC ↗ |
| 2026-10-15 | Chief Scientific Officer Lillie James Woodruff | sold | $93K | SEC ↗ |
| 2026-10-15 | General Counsel Hanson Kristopher | sold | $73K | SEC ↗ |
185 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-10-15 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) ROBERT MALENKA | filed notice to sell | $116K | SEC ↗ |
| 2026-10-15 | Officer (via Jefferies LLC) Lillie James Woodruff | filed notice to sell | $90K | SEC ↗ |
| 2026-10-15 | Officer (via Jefferies LLC) Kroeger Christopher A. | filed notice to sell | $576K | SEC ↗ |
| 2026-10-15 | Officer (via Jefferies LLC) Foff Erin Pennock | filed notice to sell | $120K | SEC ↗ |
| 2026-10-15 | Officer (via Jefferies LLC) GILLIS JONATHAN | filed notice to sell | $79K | SEC ↗ |
| 2026-10-15 | Officer (via Jefferies LLC) Hanson Kristopher | filed notice to sell | $70K | SEC ↗ |
| 2026-10-15 | Chief Medical Officer Foff Erin Pennock | sold | $124K | SEC ↗ |
| 2026-10-15 | Chief Discovery Officer Kreitzer Anatol | sold | $96K | SEC ↗ |
| 2026-09-16 | General Counsel Hanson Kristopher | sold | $193K | SEC ↗ |
| 2026-09-16 | Officer (via Jefferies LLC) Hanson Kristopher | filed notice to sell | $199K | SEC ↗ |
| 2026-08-20 | 5%+ holder (13G) Pivotal bioVenture Partners Fund II, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-08-18 | Activist (13D) — increased stake Catalyst4, Inc. | increased its stake (13D/G amendment) | — | SEC ↗ |
| 2026-08-03 | Activist (13D) — increased stake Catalyst4, Inc. | increased its stake (13D/G amendment) | — | SEC ↗ |
| 2026-08-03 | Chief Scientific Officer Lillie James Woodruff | sold | $277K | SEC ↗ |
| 2026-08-03 | Officer (via Jefferies LLC) Lillie James Woodruff | filed notice to sell | $288K | SEC ↗ |
| 2026-07-30 | Former Affiliate (via Morgan Stanley & Co. LLC) Novo Holdings A/S | filed notice to sell | $24.0M | SEC ↗ |
| 2026-07-28 | Director Cox Troy | bought | $149K | SEC ↗ |
| 2026-07-17 | Chief Executive Officer Kroeger Christopher A. | sold | $636K | SEC ↗ |
| 2026-07-17 | CAO and Interim CFO GILLIS JONATHAN | sold | $638K | SEC ↗ |
| 2026-07-17 | CAO and Interim CFO GILLIS JONATHAN | sold | $34K | SEC ↗ |